2009, Number 3
Next >>
Med Sur 2009; 16 (3)
Tendencias en el uso de coloides en la Unidad de Terapia Intensiva: albúmina humana y coloides sintéticos
Aguilar RMP, Remolina SM
Language: Spanish
References: 33
Page: 124-130
PDF size: 121.44 Kb.
ABSTRACT
Objective. Set the trend in the use of colloids at the Intensive Care
Unit (ICU) over a period of 5 years.
Material and methods.
Clinical observation study in retrospective. It was included all patients
admitted to the ICU of Medica Sur Hospital in a period of five years.
It was registered: sex, average stay, medical and surgical cases, use
of mechanical ventilator (MV), use of norepinephrine as well as
administration of human albumin (HA) or synthetic colloids. A descriptive
analysis was performed using percentages in order to apply
then the chi-square statistical test to evaluate differences between
percentages.
Results. 1,569 patients were included, 53.98% were
males and 46.02% women. The medical cases were 46% and 53%
surgical. In 69.02% were administered AH, synthetic colloids or both
and 30.98% none of them. In the period studied the use of HA was
increased by 370% and in conjunction with synthetic colloids the
increase was of 362%. The use of synthetic colloid without HA decreased
337%. There was a significant trend to increase the administration
of HA, synthetic colloids or both, according to: surgical patients
(57.2%) compared with medical cases (42%); regarding the
days of stay in ICU, patients with ‹10 days of stay the administration
was 65.12% and ›10 days of stay was 100%; with concomitant use of
norepinephrine was 57.24% and patients with employment of MV
was 63.25%. All of these variables with p value ≤ 0.001.
Conclusions.
There is a clear upward trend in the administration of HA alone
or in combination with synthetic colloids and a decrease in use of
synthetic colloids without HA on patients in the ICU. Patients who
used more colloids were surgical cases, those with the highest number
of days of stay in ICU, those who used the MV and those who
used norepinephrine.
REFERENCES
Vincent JL, Gerlach H. Fluid resuscitation in severe sepsis and septic shock: An evidence based review. Crit Care Med 2004; 32: S451-S454.
Vincent JL, Weil MH. Fluid challenge revisited. Crit Care Med 2006; 34: 1333-7.
Choi PT, Yip G, Quinonez LG, et al. Crystaloids vs. Colloids in fluid resuscitation: A systematic review. Crit Care Med 1999; 27: 200-10.
Bellomo R. Fluid resuscitation. Colloids vs. crystalloids. Blood Purif 2002; 20: 239-42.
Treib J, Baron JF, Grauer MY, et al. An international view of hydroxyethyl starches. Intensive Care Med 1999; 25: 258-68.
Dellinger RP, Levy MM; Carlet JM, et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008; 36: 296-327.
Boldt J. The Good, the Bad, and the Ugly: Should We Completely Banish Human Albumin from Our Intensive Care Units?. Anesth Analg 2000; 91: 887-95.
Schierhout G, Roberts J. Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: A systematic review of randomized trials. BMJ 1998; 316: 961-4.
Cochrane Injuries Group Albumin Reviewers. Human albumin administration in critically ill patients: Systematic review of randomized controlled tirals. BMJ 1998: 317: 235-40.
Martin GS. Pharmacological aspects of albumin as a niche product in the intensive care Unit. Crit Care Med 2005; 33: 1667-9.
Dubois MJ, Vincent JL. Use of albumin in the intensive care unit. Current Opinion in Critical Care 2002; 8: 299-301.
Wilkes MM, Navickis RJ. Patient survival after human albumin administration. Ann Intern Med 2001; 135: 149-64.
Finfer S, Bellomo R, Boyce N, et al. SAFE Study Investigators: A comparison of albumin and saline for fluid resuscitatiton in the intensive care unit. N Engl H Med 2004; 350: 2247-56.
Roberts I. Saline is as effective as albumin for fluid resuscitation in critically ill people. Evidence-Based Healthcare-Public Health 2004; 8: 389-91.
Riegger L, Voepel-Lewis T, Kulik T, et al. Albumin versus crystalloid prime solution for cardiopulmonary bypass in Young children. Crit Care Med 2002; 30: 2649-54.
Boldt J, Brosch C, Ducke M, et al. Influence of volumen therapy with a modern hydroxyethylstarch preparation on kidney function in cardiac surgery patients with compromised renal function: A comparison with human albumin. Crit Care Med 2007; 35: 2740-6.
Lang J, Chaiwat O. Clinical use of hydroxyethylstarch: Colloidal confusión or clarity? Crit Care Med 2007; 35: 2864-6.
Jungheinrich C, Neff TA. Pharmacokinetics of hydroxyethyl starch. Clin Pharmacokinet 2005; 44: 681-99.
Sark Y, Payen D, Reinhart K, et al. Effects of hydroxyethyl starch administration on renal function in critically ill patients. Br J Anaesth 2007; 98: 216-24.
von Hoegen I, Waller C. Safety of human albumin based on spontaneously reported serious adverse events. Crit Care Med 2001; 29: 994-6.
Uhing MR. The albumin controversy. Clin Perinatol 2004; 31: 475-88.
Martin GS. A new twist on albumin therapy in the intensive care uint, again. Crit Care Med 2006; 34: 2677-9.
Quinlan GJ, Margarson MP, Mumby S, et al. Administration of albumin to patients with sepsis syndrome: a posible beneficial role in plasma thiol repletion. Clin Sci 1998; 95: 459-65.
Quinlan GJ, Mumby S, Martin GS, et al. Albumin influences total plasma antioxidant capacity favorably in patients with acute lung injury. Crit Care Med 2004; 32: 755-9.
Dubois MJ, Orellana-Jimenez C, Melot Ch, et al. Albumin administration improves organ function in critically ill hipoalbuminemic patients: A prospective, randomized, controlled pilot study. Crit Care Med 2006; 34: 2536-40.
Horstick G, Lauterbach M, Kempf T, et al. Early albumin infusion improves global and local hemodynamics and reduces inflammatory response in hemorrhagic shock. Crit Care Med 2002; 30: 851-5.
Hwang TL, Lue MC, Nee YJ, et al. The incidence of diarrhea in patients with hypoalbuminemia due to acute or chronic malnutrition during enteral feeding. Am J Gastroenterol 1994; 89: 376-8.
Vincent JL, Dubois MJ, Navickis R, et al. Hypoalbuminemia in Acute Illness: Is There a Rationale for Intervention? A Meta- Analysis of Cohort Studies and Controlled Trials. Annals of Surgery 2003; 237: 319-34.
Gines P, Cardenas A, Arroyo V, et al. Management of cirrhosis and ascites. N Engl J Med 2004; 350: 1646-54.
Martin GS, Mangialardi RJ, Wheeler AP, et al. Albumin and furosemide therapy in hypoproteinemic patients with acute lung injury. Crit Care Med 2002; 30: 2175-82.
Martin GS, Moss M, Wheeler AP, et al. A randomized, controlled trial of furosemide with or without albumin in hypoproteinemic patients with acute lung injury. Crit Care Med 2005; 33: 1681-7.
Vincent JL, Navickis R, Wilkes MM. Morbidity in hospitalized patients receiving human albumin: A metaanalysis of randomized, controlled trials. Crit Care Med 2004; 32: 2029-38.
Vincent JL. Fluid management: The pharmacoeconomic dimension. Crit Care 2000; 4 (Suppl. 2): S33-S35.